论文部分内容阅读
目的:观察显微喉镜下CO2激光手术治疗早期喉癌的远期疗效和生存质量。方法:对20例喉癌患者在显微喉镜下行CO2激光手术。全部病例通过电话、书信和来院复诊等形式随访5～8年。结果:20例患者中,1例术后1年死于局部复发,1例术后2年局部复发行部分喉切除术,1例术后5年出现颈部淋巴结转移行二期颈廓清术,其余17例术后随访5～8年未见复发。5年总治愈率为85%,生存率为95%,局部复发率为10%,局部淋巴结转移率为5%。所有存活者呼吸通畅,发声良好,其中8例完全恢复日常工作,5例经常从事家务劳动,4例有时从事家务劳动。结论:T1及更早期的声门区和声门上区喉癌适合显微喉镜CO2激光手术,其5年生存率及生存质量令人满意,是治疗早期喉癌的较好选择。
Objective: To observe the long-term efficacy and quality of life of laryngeal laryngeal carcinoma treated by CO2 laryngoscope. Methods: Twenty patients with laryngeal carcinoma underwent CO2 laser surgery under the laryngoscope. All cases were followed up for 5 ~ 8 years by telephone, letters and visits to hospital. Results: Of the 20 patients, 1 died of local recurrence 1 year after operation, 1 had partial laryngectomy 2 years after operation, 1 had neck lymph node metastasis 5 years after operation, The remaining 17 cases were followed up for 5 to 8 years without recurrence. The 5-year overall cure rate was 85%, the survival rate was 95%, the local recurrence rate was 10%, and the local lymph node metastasis rate was 5%. All survivors breathed freely and gave good vocalizations, of which 8 were fully restored to their daily work, 5 were regularly engaged in housework and 4 were sometimes engaged in housework. CONCLUSIONS: T1 and earlier glottic and supraglottic laryngeal carcinoma are suitable for microlaryngoscopic CO2 laser surgery. Their 5-year survival rate and quality of life are satisfactory, which is a good choice for the treatment of early laryngeal cancer.